- Home
- MIRM vs BTMWW Comparison
MIRM vs BTMWW Comparison
Compare MIRM & BTMWW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MIRM | BTMWW |
|---|---|---|
| Founded | 2018 | N/A |
| Country | United States | United States |
| Employees | N/A | 126 |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | N/A |
| IPO Year | 2019 | 2022 |
Fundamental Metrics
Financial Performance| Metric | MIRM | BTMWW |
|---|---|---|
| Price | $67.34 | $0.12 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 11 | 0 |
| Target Price | ★ $87.55 | N/A |
| AVG Volume (30 Days) | ★ 560.0K | N/A |
| Earning Date | 11-04-2025 | N/A |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $471,794,000.00 | N/A |
| Revenue This Year | $53.78 | N/A |
| Revenue Next Year | $19.91 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 53.66 | N/A |
| 52 Week Low | $36.88 | N/A |
| 52 Week High | $78.55 | N/A |
Technical Indicators
Market Signals| Indicator | MIRM | BTMWW |
|---|---|---|
| Relative Strength Index (RSI) | 45.04 | 39.45 |
| Support Level | $63.23 | $0.10 |
| Resistance Level | $66.77 | $0.14 |
| Average True Range (ATR) | 3.05 | 0.02 |
| MACD | -0.46 | 0.00 |
| Stochastic Oscillator | 32.98 | 31.00 |
Price Performance
Historical ComparisonAbout MIRM Mirum Pharmaceuticals Inc.
Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.
About BTMWW Bitcoin Depot Inc. Warrant
Bitcoin Depot Inc owns and operates the widest network of BTMs across North America where customers can buy and sell Bitcoin. Bitcoin Depot helps power the digital economy for users of cash. It has locations across the U.S. and Canada at, among others, the following types of retailers: Convenience Stores and Gas Station Chains, Pharmacies and Grocers and Mall Operators.